Found: 19
Select item for more details and to access through your institution.
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6442, doi. 10.3390/ijms22126442
- By:
- Publication type:
- Article
Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 12, p. 2773, doi. 10.3390/ijms18122773
- By:
- Publication type:
- Article
Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic Development.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characterization of the pharmacokinetics, pharmacodynamics, and distribution of anti-abeta antibody MABT5102A
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 554, doi. 10.1208/s12248-012-9369-y
- By:
- Publication type:
- Article
Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 612, doi. 10.1208/s12248-012-9374-1
- By:
- Publication type:
- Article
Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017874
- By:
- Publication type:
- Article
Enhancing brain entry and therapeutic activity of chimeric antigen receptor T cells with intra-arterial NEO100 in a mouse model of CNS lymphoma.
- Published in:
- Journal of Neurosurgery, 2024, v. 140, n. 6, p. 1549
- By:
- Publication type:
- Article
Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor models.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 5, p. 511, doi. 10.1007/s00262-016-1813-x
- By:
- Publication type:
- Article
Identification of a protein fragment of interleukin 2 responsible for vasopermeability.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors.
- Published in:
- Cancer (0008543X), 1994, v. 73, n. S3, p. 824, doi. 10.1002/1097-0142(19940201)73:3+<824::AID-CNCR2820731312>3.0.CO;2-V
- By:
- Publication type:
- Article
Differential Effects of Predosing on Tumor and Tissue Uptake of an <sup>111</sup>In-Labeled Anti-TENB2 Antibody–Drug Conjugate.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1454, doi. 10.2967/jnumed.112.103168
- By:
- Publication type:
- Article
Spatio-temporal biodistribution of 89Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor model.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94490-0
- By:
- Publication type:
- Article
Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations.
- Published in:
- Antibodies (2073-4468), 2020, v. 9, n. 2, p. 22, doi. 10.3390/antib9020022
- By:
- Publication type:
- Article
An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2.
- Published in:
- British Journal of Pharmacology, 2013, v. 168, n. 2, p. 445, doi. 10.1111/j.1476-5381.2012.02138.x
- By:
- Publication type:
- Article
Maximizing tumour exposure to anti-neuropilin-1 antibody requires saturation of non-tumour tissue antigenic sinks in mice.
- Published in:
- British Journal of Pharmacology, 2012, v. 166, n. 1, p. 368, doi. 10.1111/j.1476-5381.2011.01777.x
- By:
- Publication type:
- Article
Characterization of Therapeutic Monoclonal Antibodies Reveals Differences Between In Vitro and In Vivo Time-Course Studies.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 1, p. 167, doi. 10.1007/s11095-012-0860-z
- By:
- Publication type:
- Article
Single Amino Acid Substitution in the Fc Region of Chimeric TNT-3 Antibody Accelerates Clearance and Improves Immunoscintigraphy of Solid Tumors.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 2, p. 355
- By:
- Publication type:
- Article